This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Digging into the Phase III SUMMIT clinical trial of tirzepatide in patients with heart failure
Ticker(s): LLY, NVOWho's the expert?
Institution: UCSD
- Director of the Advanced Heart Failure Treatment Program at UC San Diego Health
- Clinical research focuses on understanding mechanisms of cardiac dysfunction and developing new heart failure therapies; has served on the executive steering committees of numerous international multicenter heart failure trials including most recently RELAX-AHF2, RELAX-AHF Asia, COMMANDER-HF (co-chair) and DREAM-HF (co-chair).
- Directs a basic science laboratory that studies the molecular basis of cardiac remodeling, myocardial fibrosis and the development of novel therapies.
Interview GoalThis call will feature a discussion on the current standard of care and the potential of tirzepatide, a GLP-1 and GIP receptor agonist for reducing the risk of heart failure.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
